These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33767986)

  • 41. Downregulation of miR-429 contributes to the development of drug resistance in epithelial ovarian cancer by targeting ZEB1.
    Zou J; Liu L; Wang Q; Yin F; Yang Z; Zhang W; Li L
    Am J Transl Res; 2017; 9(3):1357-1368. PubMed ID: 28386361
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-222 promotes invasion and migration of ovarian carcinoma by targeting PTEN.
    Gong L; Zhang W; Yuan Y; Xing X; Li H; Zhao G
    Oncol Lett; 2018 Jul; 16(1):984-990. PubMed ID: 29963173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells.
    Pink RC; Samuel P; Massa D; Caley DP; Brooks SA; Carter DR
    Gynecol Oncol; 2015 Apr; 137(1):143-51. PubMed ID: 25579119
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
    Wu DD; Li XS; Meng XN; Yan J; Zong ZH
    Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
    Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.
    Zhao YS; Yang WC; Xin HW; Han JX; Ma SG
    Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through
    Vera O; Jimenez J; Pernia O; Rodriguez-Antolin C; Rodriguez C; Sanchez Cabo F; Soto J; Rosas R; Lopez-Magallon S; Esteban Rodriguez I; Dopazo A; Rojo F; Belda C; Alvarez R; Valentin J; Benitez J; Perona R; De Castro J; Ibanez de Caceres I
    Theranostics; 2017; 7(17):4118-4134. PubMed ID: 29158814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.
    Zhang Y; Huang S; Guo Y; Li L
    Biomed Pharmacother; 2018 Oct; 106():1357-1363. PubMed ID: 30119207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Regulatory effects and associated mechanisms of miR-130a molecules on cisplatin resistance in ovarian cancer A2780 cell lines].
    Li NW; Wang HJ; Yang LY; Jia XB; Chen C; Wang X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Nov; 44(6):865-70. PubMed ID: 24490491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-203 regulates DJ-1 expression and affects proliferation, apoptosis and DDP resistance of pancreatic cancer cells.
    Du SL; Xu LY; Gao P; Liu QS; Lu FF; Mo ZH; Fan ZZ; Cheng XL; Dong ZH
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8833-8840. PubMed ID: 31696470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
    Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum miR-486-5p as a diagnostic marker in cervical cancer: with investigation of potential mechanisms.
    Li C; Zheng X; Li W; Bai F; Lyu J; Meng QH
    BMC Cancer; 2018 Jan; 18(1):61. PubMed ID: 29316891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression.
    Yao L; Wang L; Li F; Gao X; Wei X; Liu Z
    Int J Clin Exp Med; 2015; 8(9):15198-205. PubMed ID: 26629004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
    Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
    Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. miR-181 regulates cisplatin-resistant non-small cell lung cancer via downregulation of autophagy through the PTEN/PI3K/AKT pathway.
    Liu J; Xing Y; Rong L
    Oncol Rep; 2018 Apr; 39(4):1631-1639. PubMed ID: 29484437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silencing of miR-19a-3p enhances osteosarcoma cells chemosensitivity by elevating the expression of tumor suppressor PTEN.
    Zhang B; Liu Y; Zhang J
    Oncol Lett; 2019 Jan; 17(1):414-421. PubMed ID: 30655782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling.
    Fang Y; Xu C; Fu Y
    J Biol Res (Thessalon); 2015 Dec; 22():12. PubMed ID: 26500892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-92b regulates the cell growth, cisplatin chemosensitivity of A549 non small cell lung cancer cell line and target PTEN.
    Li Y; Li L; Guan Y; Liu X; Meng Q; Guo Q
    Biochem Biophys Res Commun; 2013 Nov; 440(4):604-10. PubMed ID: 24099768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN.
    Lei L; Huang Y; Gong W
    Oncol Rep; 2013 Dec; 30(6):2897-902. PubMed ID: 24084898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.